Navigation Links
Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product Liability Lawsuits
Date:3/7/2008

state's most challenging class action and mass tort litigations. Since her retirement from the court, Judge Corodemus has practiced at Corodemus and Corodemus LLC in Iselin, New Jersey, where she heads the Alternative Dispute Resolution department.

Resolution Program

The resolution program for VIOXX claims in the United States, which was announced on November 9, 2007, is moving forward. Merck & Co., Inc., said on March 3, 2008, that more than 44,000 of the approximately 47,000 individuals who registered eligible injuries have submitted some or all of the materials required for enrollment that could qualify them for an interim payment in the program to resolve state and federal myocardial infarction (MI) and ischemic stroke (IS) claims filed against the Company in the United States.

If all of these eligible submissions are completed in accordance with the Settlement Agreement, this would represent more than 93 percent of the eligible MI and IS claims previously registered with the program.

Currently, Merck is working with the Claims Administrator to examine the registration and enrollment materials that have been received and continue to come in for interim payments. There is a considerable amount of documentation that has to be reviewed before the definitive determination can be made that the thresholds have been met.

Merck is confident that 85% thresholds will be met and exceeded, which will obligate the Company to pay $4.85 billion into the resolution fund.

Claimants who submitted initial enrollment materials by February 29 have until March 31 to complete their enrollment for interim payments. Interim payments could begin as early as August. Eligible claimants who do not qualify for interim payments may still enroll in the resolution program if the claims were filed or tolled prior to Nov. 9, 2007 and their claims will be counted toward the participation thresholds as provided by the agreements. The current dea
'/>"/>

SOURCE Hughes Hubbard & Reed LLP and Herman Herman Katz & Cotlar,LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... San Diego, CA (PRWEB) October 20, 2014 ... regarding all the latest information from the FDA on ... consumers on October 10 not to purchase or use Sit ... Phenolphthalein. Sit and Slim II is promoted as weight loss ... , Sibutramine, removed from the market in 2010 for safety ...
(Date:10/20/2014)... 2014 Based on a proprietary ... imaging assays capable of determining DNA sequence, location ... these three dimensions of high-resolution data, dGH assays ... widest range of disease-causing genetic rearrangements, including chromosomal ... genomic tools, including today’s advanced sequencing technologies. , ...
(Date:10/20/2014)... It’s hard to imagine what it’s like ... children around the world, it’s a reality. And while new ... are forced to walk barefoot on rocky terrain or sewage-lined ... with their friends. , Buckner International's Shoes for ... in October to encourage support for Air1 and while ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law ... greater Phoenix area and across Arizona reports record demand ... automobile accidents. Statistics have indicated a steady increase in ... such, Hastings and Hastings has seen a steady increase ... have been injured through no fault of their own ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... In the first ever threadbare genetic study of Alzheimer’s, reports ... 79% of the cases, is genetically linked. // ... to it. The disease is marked by apparent confusion, memory ... a place in the Archives of General Psychiatry,However genes cannot ...
... has been an increase in heart failure cases among the elderly, ... men surviving for longer periods. There has been a 14% increase ... period when compared to the 1970 to 1974 period, in the ... ,The chances of heart failure occurring among people ...
... produced by Roche Pharmaceuticals, has been approved by the ... prevention drug in children’s between the ages of 1 ... leading healthcare company situated in Switzerland and are manufacturers ... to be an effective influenza virus drug, which inhibits ...
... leaders, particularly in South Asia to prohibit smoking among the ... the British Medical Journal (BMJ). The help of the Muslim ... ,The researchers analyzed data on the prevalence of smoking ... Smoking rates in each of these countries is significantly higher ...
... who suffer from eating disorders do not reveal it to anyone ... six months. As many as 1,000 youngsters were studied, and the ... of recognizing such disorders in their children, while only 21% of ... ,The research was conducted by the Eating Disorders Association ...
... charges cost so dear, that cancer patients, ill afford ... Charity Breast Cancer Care, 42% of breast cancer patients, ... financial incapacity to afford the prescription charges. Out of ... 15% said they were forced to discontinue the treatment ...
Cached Medicine News:Health News:Eating Disorders Among Children Are Widespread 2
(Date:10/20/2014)... 20, 2014 Pharmaceutic Labs announces the opening ... Albany, NY for admixing, compounding, drug ... and/or exceeds the FDA standards for safety and quality, ... 211. The 10,000 square foot outsourcing ... quality assurance and quality control. The company will produce ...
(Date:10/19/2014)... , Oct. 20, 2014 CTI BioPharma ... it will report its third quarter 2014 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:10/17/2014)... 2014  Training market researchers to spot and ... in today,s highly competitive global marketplace. As resources ... effectively and efficiently produce high performing analysts, regardless ... Effective training programs can help these ... internal clients by developing analysts who can drive ...
Breaking Medicine Technology:CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: